Wu Yifeng, Li Xianpeng, Chen Mingliang, Liu Zhikun, Zhang Xuanyu, Zheng Shusen, Xu Xiao
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310006, P.R. China.
Oncol Lett. 2021 Mar;21(3):177. doi: 10.3892/ol.2021.12438. Epub 2021 Jan 6.
Hepatocellular carcinoma (HCC) constitutes a deadly cancer with a high rate of recurrence and metastasis. Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes-15 (PED/PEA-15) is a protein involved in the metabolism of glucose that regulates numerous cellular processes, including cell division, apoptosis and migration in numerous types of cancer. However, PED/PEA-15 may act as a tumor-promotor or a tumor-suppressor depending on its phosphorylation status. In the present study, the association between the phosphorylation of PED/PEA-15 at Ser116 [PED/PEA-15(S116)], the phosphorylation of P27 at Thr187 [P-p27(T187)] and the clinicopathological features and prognosis of patients with HCC was assessed. The levels of PED/PEA-15(S116) and P-p27(T187) were determined using immunohistochemistry and western blotting analysis in resected liver tumor tissues and adjacent non-cancerous tissues obtained from 60 patients with HCC as well as normal liver tissues from 12 patients with benign lesions. The association between the expression levels of these two markers and the clinicopathological features of patients with HCC was explored. Using the Kaplan-Meier method, the prognostic value of PED/PEA-15(S116) and P-p27(T187) expression levels was determined. The results demonstrated that the levels of PED/PEA-15(S116) and P-p27(T187) proteins were remarkably higher in the HCC group compared with those in the adjacent and normal tissue groups (both P<0.05). In addition, a moderate positive correlation was observed between the levels of PED/PEA-15(S116) and P-p27(T187) (r=0.434; P<0.05). The levels of these two proteins were associated with the Edmondson grade, Tumor-Node-Metastasis (TNM) stage, vascular invasion and tumor multiplicity (all P<0.05). Furthermore, the Kaplan-Meier analysis results demonstrated that patients with HCC that presented with positive expression of PED/PEA-15(S116) and P-p27(T187) exhibited a dismal prognosis compared with that in patients with negative expression regarding the overall survival (OS), as well as disease-free survival (both P<0.05). Multivariate Cox analysis revealed that the TNM stage (P<0.05), vascular invasion (P<0.05), PED/PEA-15(S116) levels (P<0.001) and P-p27(T187) levels (P<0.05) were independent prognostic factors for OS in patients with HCC. In conclusion the results of the present study demonstrated that PED/PEA-15(S116) and P-p27(T187) levels were upregulated in HCC tissues compared with those in the adjacent and normal tissues; PED/PEA-15(S116) and P-p27(T187) expression may serve as an indicator of a poor prognosis in patients with HCC, suggesting that these proteins may be prospective therapeutic targets for HCC.
肝细胞癌(HCC)是一种致命的癌症,复发率和转移率很高。富含糖尿病的磷蛋白/富含星形胶质细胞的磷蛋白-15(PED/PEA-15)是一种参与葡萄糖代谢的蛋白质,它调节许多细胞过程,包括多种癌症中的细胞分裂、凋亡和迁移。然而,PED/PEA-15根据其磷酸化状态可能充当肿瘤促进剂或肿瘤抑制剂。在本研究中,评估了丝氨酸116处PED/PEA-15的磷酸化[PED/PEA-15(S116)]、苏氨酸187处P27的磷酸化[P-p27(T187)]与HCC患者的临床病理特征及预后之间的关联。采用免疫组织化学和蛋白质印迹分析方法,检测了60例HCC患者切除的肝肿瘤组织及癌旁非癌组织以及12例良性病变患者的正常肝组织中PED/PEA-15(S116)和P-p27(T187)的水平。探讨了这两种标志物的表达水平与HCC患者临床病理特征之间的关联。采用Kaplan-Meier法确定PED/PEA-15(S116)和P-p27(T187)表达水平的预后价值。结果表明,与癌旁组织和正常组织组相比,HCC组中PED/PEA-15(S116)和P-p27(T187)蛋白水平显著更高(均P<0.05)。此外,PED/PEA-15(S116)和P-p27(T187)水平之间存在中度正相关(r=0.434;P<0.05)。这两种蛋白的水平与Edmondson分级、肿瘤-淋巴结-转移(TNM)分期、血管侵犯和肿瘤多灶性均相关(均P<0.05)。此外,Kaplan-Meier分析结果表明,PED/PEA-15(S116)和P-p27(T187)呈阳性表达的HCC患者在总生存期(OS)和无病生存期方面的预后均较阴性表达患者差(均P<0.05)。多因素Cox分析显示,TNM分期(P<0.05)、血管侵犯(P<0.05)、PED/PEA-15(S116)水平(P<0.001)和P-p27(T187)水平(P<0.05)是HCC患者OS的独立预后因素。总之,本研究结果表明,与癌旁组织和正常组织相比,HCC组织中PED/PEA-15(S116)和P-p27(T187)水平上调;PED/PEA-15(S116)和P-p27(T187)表达可能是HCC患者预后不良的指标,提示这些蛋白可能是HCC潜在的治疗靶点。